[Expert consensus on lipid management in panvascular diseases (2025 edition)]

Area of Science:

• Cardiovascular Medicine
• Endocrinology
• Vascular Surgery

Background:

• Panvascular disease, characterized by atherosclerosis, is a major cause of death globally and in China.
• Dyslipidemia is a primary driver of atherosclerosis, yet its management in Chinese panvascular disease patients faces challenges.
• Existing lipid management strategies require adaptation for the Chinese population.

Purpose of the Study:

• To develop the "Chinese Expert Consensus on Lipid Management for Panvascular Disease" to address current management gaps.
• To provide evidence-based recommendations for standardized dyslipidemia management in this patient group.
• To offer practical guidance for clinicians to improve patient outcomes and reduce atherosclerotic events.

Main Methods:

• A multidisciplinary expert panel reviewed the latest domestic and international clinical evidence and guidelines.
• The consensus development involved comprehensive literature review and expert consensus building.
• Recommendations cover risk stratification, lipid targets, lifestyle changes, and pharmacologic therapies.

Main Results:

• The consensus outlines standardized approaches for lipid management in panvascular disease.
• It provides specific recommendations on risk assessment, target lipid values, and treatment strategies.
• The document emphasizes individualized care and multidisciplinary coordination.

Conclusions:

• The "Chinese Expert Consensus on Lipid Management for Panvascular Disease" offers a vital framework for clinicians.
• Implementing these recommendations can optimize lipid management and mitigate cardiovascular risks.
• This consensus aims to improve long-term outcomes for patients with panvascular disease in China.